Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-28

FDA Approved: MEMANTINE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved Chartwell RX LLC's supplemental application for memantine. This action approves a supplemental filing for a generic memantine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Memantine (memantine)

Snippet

SUPPL AP for MEMANTINE (MEMANTINE)